These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29879466)

  • 1. A paradoxical thrombogenic mutation in factor II at the target site of arthropod bleeding toxin.
    Takenouchi T; Shimada H; Uehara T; Kanai Y; Takahashi T; Kosaki K
    Eur J Med Genet; 2019 Feb; 62(2):93-95. PubMed ID: 29879466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug.
    Fuentes-Prior P; Noeske-Jungblut C; Donner P; Schleuning WD; Huber R; Bode W
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11845-50. PubMed ID: 9342325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
    Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
    Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of a thrombin exosite I inhibitor triabin in Escherichia coli and elucidation of the role of key residues in its inhibitory activity.
    Mo Z; Xiao Z; He C
    Biochimie; 2023 May; 208():13-19. PubMed ID: 36580989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triabin, a highly potent exosite inhibitor of thrombin.
    Noeske-Jungblut C; Haendler B; Donner P; Alagon A; Possani L; Schleuning WD
    J Biol Chem; 1995 Dec; 270(48):28629-34. PubMed ID: 7499380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.
    Ding Q; Yang L; Zhao X; Wu W; Wang X; Rezaie AR
    Thromb Haemost; 2017 Feb; 117(3):479-490. PubMed ID: 27975099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral venous thrombosis and familial prothrombin gene G20210a mutation].
    Verdelho A; Ferro JM; Palmeiro A; Antunes C
    Rev Neurol; 2001 Aug 16-31; 33(4):335-8. PubMed ID: 11588727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
    Beye A; Pindur G
    Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thrombin-mediated cellular effects by triabin, a highly potent anion-binding exosite thrombin inhibitor.
    Glusa E; Bretschneider E; Daum J; Noeske-Jungblut C
    Thromb Haemost; 1997 Jun; 77(6):1196-200. PubMed ID: 9241757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems.
    Lichy C; Dong-Si T; Reuner K; Genius J; Rickmann H; Hampe T; Dolan T; Stoll F; Grau A
    J Neurol; 2006 Mar; 253(3):316-20. PubMed ID: 16155788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated cortical vein thrombosis associated with prothrombin gene mutation.
    Giraldo EA; Arora R; Koenigsberg RA
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):791-3. PubMed ID: 23834854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation of the prothrombin gene (G20210A) in a patient with cerebral venous sinus thrombosis and bilateral deep vein thrombosis].
    Ortín X; Ugarriza A; Escoda L; Mesa R
    Med Clin (Barc); 2004 Feb; 122(4):158. PubMed ID: 14967101
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral vein thrombosis and prothrombin gene (G20210A) mutation.
    Heckmann JG; Tomandl B; Erbguth F; Neidhardt B; Zingsem H; Neundörfer B
    Clin Neurol Neurosurg; 2001 Oct; 103(3):191-3. PubMed ID: 11532562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.